Acquisitions26 Sept 2026, 05:00 pm
Dr. Lal PathLabs Subsidiary Completes 80% Stake Acquisition in Sunshine Healthcare
AI Summary
Dr. Lal PathLabs FZCO, Dubai, a wholly-owned subsidiary of Dr. Lal PathLabs Ltd, has successfully completed the acquisition of an 80% stake in Sunshine Healthcare Limited (SHL), Ghana. This transaction makes SHL a step-down subsidiary of Dr. Lal PathLabs Ltd. The company had previously intimated the Board's approval for this acquisition on July 24, 2026. All necessary disclosures as per SEBI regulations have been made.
Key Highlights
- Dr. Lal PathLabs subsidiary acquired 80% stake in Sunshine Healthcare.
- Sunshine Healthcare is now a step-down subsidiary.
- Acquisition aligns with previous board approvals.
- All regulatory disclosures have been completed.
Price Impact
More from LALPATHLAB